R&D expense · 2018–2025

Viemed Healthcare R&D expense

$3.0M−1.7% · FY2025

Viemed Healthcare (VMD) reported $3.0M in R&D expense for fiscal 2025, −1.7% year on year.

$02018$848,0002019$1.1M2020$2.1M2021$2.7M2022$2.8M2023$3.1M2024$3.0M2025
Viemed Healthcare — R&D expense, 2018–2025
Fiscal yearR&D expenseChangeFiling
FY20252025-12-31$3.0M−1.7%Open →
FY20242024-12-31$3.1M+10.3%Open →
FY20232023-12-31$2.8M+3.2%Open →
FY20222022-12-31$2.7M+27.8%Open →
FY20212021-12-31$2.1M+94.8%Open →
FY20202020-12-31$1.1M+27.7%Open →
FY20192019-12-31$848,000+$848,000Open →
FY20182018-12-31$0—Open →

R&D expense — Research and development expense is what the company charged to R&D in the income statement for the year. Most companies report no R&D at all — the line is absent rather than zero — so this ranking covers the roughly 40% of filers that do.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026

R&D expense at companies of similar size

Full ranking by R&D expense →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Viemed Healthcare R&D expense |url=https://companiesranked.com/en/company/viemed-healthcare/research-and-development-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Viemed Healthcare R&D expense. CompaniesRanked. https://companiesranked.com/en/company/viemed-healthcare/research-and-development-expense

BibTeX

@misc{companiesranked-en-company-viemed-healthcare-research-and-development-expense-2026,
  author       = {{CompaniesRanked}},
  title        = {{Viemed Healthcare R\&D expense}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/viemed-healthcare/research-and-development-expense}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001729149-26-000009 · March 4, 2026

{{cite web |title=Viemed Healthcare R&D expense — 10-K (0001729149-26-000009) |url=https://www.sec.gov/Archives/edgar/data/1729149/000172914926000009/vmd-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-04}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Viemed Healthcare overview